Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1977-06-15
1978-05-23
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544353, 544395, A61K 31495, C07D24140
Patent
active
040911012
ABSTRACT:
6-(1-Piperazinyl)quinoxaline and pharmaceutically acceptable salts thereof have serotoninmimetic activity. It is prepared by reducing the nitro group of 1-(3-amino-4-nitrophenyl)piperazine followed by treatment with glyoxal.
REFERENCES:
patent: 3538097 (1970-11-01), Loewe et al.
patent: 3594418 (1971-07-01), Gilbert
patent: 3919223 (1975-11-01), Zmojdzin
Lumma, Jr. William C.
Saari Walfred S.
Anderson, Jr. Rudolph J.
Coughlan, Jr. Paul M.
Katz Martin L.
Merck & Co. , Inc.
Monaco Mario A.
LandOfFree
6-(1-Piperazinyl)quinoxaline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-(1-Piperazinyl)quinoxaline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(1-Piperazinyl)quinoxaline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-564603